The Ccr4‐Not complex is a key regulator of eukaryotic gene expression

MA Collart - Wiley Interdisciplinary Reviews: RNA, 2016 - Wiley Online Library
The Ccr4‐Not complex is a multisubunit complex present in all eukaryotes that contributes to
regulate gene expression at all steps, from production of messenger RNAs (mRNAs) in the …

Multifunctional roles of the mammalian CCR4–NOT complex in physiological phenomena

YT Shirai, T Suzuki, M Morita, A Takahashi… - Frontiers in …, 2014 - frontiersin.org
The carbon catabolite repression 4 (CCR4)–negative on TATA-less (NOT) complex serves
as one of the major deadenylases of eukaryotes. Although it was originally identified and …

RNA helicase DDX6 and scaffold protein GW182 in P-bodies promote biogenesis of stress granules

V Majerciak, T Zhou, MJ Kruhlak… - Nucleic Acids …, 2023 - academic.oup.com
Two prominent cytoplasmic RNA granules, ubiquitous RNA-processing bodies (PB) and
inducible stress granules (SG), regulate mRNA translation and are intimately related. In this …

Personalized immunotherapy against several neuronal and brain tumors

S Kuttruff-coqui, T Weinschenk, J Fritsche… - US Patent …, 2021 - Google Patents
2014-11-12 Assigned to IMMATICS BIOTECHNOLOGIES GMBH reassignment IMMATICS
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape

P Hubel, C Urban, V Bergant, WM Schneider… - Nature …, 2019 - nature.com
Interferon-stimulated genes (ISGs) form the backbone of the innate immune system and are
important for limiting intra-and intercellular viral replication and spread. We conducted a …

Immunotherapy against several tumors, such as lung cancer, including NSCLC

T Weinschenk, S Walter, J Fritsche, S Colette… - US Patent …, 2018 - Google Patents
A method of treating a patient who has non-small cell lung carcinoma (NSCLC), lung cancer,
gastric cancer, and/or glioblastoma includes administering to said patient a composition …

Immunotherapy against several tumors, such as lung cancer, including nsclc

T Weinschenk, S Walter, J Fritsche… - US Patent App. 14 …, 2016 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
52460698&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

Cytidine-containing tails robustly enhance and prolong protein production of synthetic mRNA in cell and in vivo

CY Li, Z Liang, Y Hu, H Zhang, KD Setiasabda… - … Therapy-Nucleic Acids, 2022 - cell.com
Synthetic mRNAs are rising rapidly as alternative therapeutic agents for delivery of proteins.
However, the practical use of synthetic mRNAs has been restricted by their low cellular …

Novel immunotherapy against several tumors, such as lung cancer, including nsclc

T Weinschenk, S Walter, J Fritsche, S Colette, H Singh - 2015 - Google Patents
The present invention relates to peptides, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …

Structure and assembly of the NOT module of the human CCR4–NOT complex

A Boland, Y Chen, T Raisch, S Jonas… - Nature structural & …, 2013 - nature.com
The CCR4–NOT deadenylase complex is a master regulator of translation and mRNA
stability. Its NOT module orchestrates recruitment of the catalytic subunits to target mRNAs …